Supplementary Methods 1 from MONETTE: A Randomized Phase II Study of Ceralasertib plus Durvalumab or Ceralasertib Monotherapy in Patients with Advanced Melanoma Resistant to PD-(L)1 Inhibition
Authors:
- Max SchlaakMSMax Schlaak
- Carolina CimminielloCCCarolina Cimminiello
- Jacopo PigozzoJPJacopo Pigozzo
- Jeeyun LeeJLJeeyun Lee
- Stephan GrabbeStephan Grabbe
- Piotr RutkowskiPRPiotr Rutkowski
- Jacek MackiewiczJMJacek Mackiewicz
- Katy K. TsaiKTKaty K. Tsai
- Paolo A. AsciertoPAPaolo A. Ascierto
- Mario MandalàMario Mandalà
- Fabrizio Carnevale-SchiancaFCFabrizio Carnevale-Schianca
- Sebastian HaferkampSHSebastian Haferkamp
Open Access
- 17 July 2026
- other
- Published by American Association for Cancer Research (AACR)